Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
December 2013 Volume 43 Issue 6

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December 2013 Volume 43 Issue 6

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Cytotoxicity of Vitex agnus-castus fruit extract and its major component, casticin, correlates with differentiation status in leukemia cell lines

  • Authors:
    • Hidetomo Kikuchi
    • Bo Yuan
    • Yoshio Nishimura
    • Masahiko Imai
    • Ryota Furutani
    • Saki Kamoi
    • Misako Seno
    • Shin Fukushima
    • Shingo Hazama
    • Chieko Hirobe
    • Kunio Ohyama
    • Xiao-Mei Hu
    • Norio Takagi
    • Toshihiko Hirano
    • Hiroo Toyoda
  • View Affiliations / Copyright

    Affiliations: Department of Clinical Molecular Genetics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan, Yasuda Women's University, Faculty of Pharmacy, Asaminami-ku, Hiroshima 731-0153, Japan, Department of Cultural History, Seisen University, Shinagawa-ku, Tokyo 141-0022, Japan, Department of Clinical Pharmacology, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan, Department of Applied Biochemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan
  • Pages: 1976-1984
    |
    Published online on: October 9, 2013
       https://doi.org/10.3892/ijo.2013.2133
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

We have demonstrated that an extract from the ripe fruit of Vitex agnus-castus (Vitex) exhibits cytotoxic activities against various types of solid tumor cells, whereas its effects on leukemia cells has not been evaluated to date. In this study, the effects of Vitex and its major component, casticin, on leukemia cell lines, HL-60 and U-937, were investigated by focusing on proliferation, induction of apoptosis and differentiation. Identification and quantitation by NMR spectroscopy showed that casticin accounted for approximate 1% weight of Vitex. Dose-dependent cytotoxicity of Vitex and casticin was observed in both cell lines, and HL-60 cells were more sensitive to the cytotoxicity of Vitex/casticin compared to U-937 cells. Furthermore, compared to unstimulated HL-60 cells, phorbol 12-myristate 13-acetate (PMA)- and 1,25-dihydroxyvitamin D3 (VD3)-differentiated HL-60 cells acquired resistance to Vitex/casticin based on the results from cell viability and apoptosis induction analysis. Since the HL-60 cell line is more immature than the U-937 cell line, these results suggested that the levels of cytotoxicity of Vitex/casticin were largely attributed to the degree of differentiation of leukemia cells; that is, cell lines with less differentiated phenotype were more susceptible than the differentiated ones. RT-PCR analysis demonstrated that PMA upregulated the expression of intercellular adhesion molecule-1 (ICAM-1) in HL-60 cells, and that anti-ICAM-1 monoclonal antibody not only abrogated PMA-induced aggregation and adhesion of the cells but also restored its sensitivity to Vitex. These results suggested that ICAM-1 plays a crucial role in the acquired resistance in PMA-differentiated HL-60 cells by contributing to cell adhesion. These findings provide fundamental insights into the clinical application of Vitex/casticin for hematopoietic malignancy.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1. 

Fimognari C, Lenzi M and Hrelia P: Chemoprevention of cancer by isothiocyanates and anthocyanins: mechanisms of action and structure-activity relationship. Curr Med Chem. 15:440–447. 2008. View Article : Google Scholar : PubMed/NCBI

2. 

Yuan B, Imai M, Kikuchi H, Fukushima S, Hazama S, Akaike T, Yoshino Y, Ohyama K, Hu X, Pei X and Toyoda H: Cytocidal effects of polyphenolic compounds, alone or in combination with, anticancer drugs against cancer cells: potential future application of the combinatory therapy. Apoptosis and Medicine. Ntuli TM: InTech; Croatia: pp. 155–174. 2012

3. 

Schellenberg R: Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ. 322:134–137. 2001. View Article : Google Scholar : PubMed/NCBI

4. 

Ma L, Lin S, Chen R, et al: Treatment of moderate to severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Gynecol Endocrinol. 26:612–616. 2010. View Article : Google Scholar : PubMed/NCBI

5. 

Ohyama K, Akaike T, Hirobe C, et al: Cytotoxicity and apoptotic inducibility of Vitex agnus-castus fruit extract in cultured human normal and cancer cells and effect on growth. Biol Pharm Bull. 26:10–18. 2003.PubMed/NCBI

6. 

Ohyama K, Akaike T, Imai M, et al: Human gastric signet ring carcinoma (KATO-III) cell apoptosis induced by Vitex agnuscastus fruit extract through intracellular oxidative stress. Int J Biochem Cell Biol. 37:1496–1510. 2005. View Article : Google Scholar : PubMed/NCBI

7. 

Chen SN, Friesen JB, Webster D, et al: Phytoconstituents from Vitex agnus-castus fruits. Fitoterapia. 82:528–533. 2011.

8. 

Shen JK, Du HP, Yang M, et al: Casticin induces leukemic cell death through apoptosis and mitotic catastrophe. Ann Hematol. 88:743–752. 2009. View Article : Google Scholar : PubMed/NCBI

9. 

Lane SW, Scadden DT and Gilliland DG: The leukemic stem cell niche: current concepts and therapeutic opportunities. Blood. 114:1150–1157. 2009. View Article : Google Scholar

10. 

Collins SJ: The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood. 70:1233–1244. 1987.PubMed/NCBI

11. 

Tanaka H, Abe E, Miyaura C, et al: 1 alpha, 25-dihydroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes. Biochem Biophys Res Commun. 117:86–92. 1983. View Article : Google Scholar : PubMed/NCBI

12. 

Rovera G, Santoli D and Damsky C: Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Natl Acad Sci USA. 76:2779–2783. 1979. View Article : Google Scholar : PubMed/NCBI

13. 

Drexler HG and Minowada J: History and classification of human leukemia-lymphoma cell lines. Leuk Lymphoma. 31:305–316. 1998.PubMed/NCBI

14. 

Solary E, Bertrand R, Kohn KW, et al: Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood. 81:1359–1368. 1993.PubMed/NCBI

15. 

Vachon PH: Integrin signaling, cell survival, and anoikis: distinctions, differences, and differentiation. J Signal Transduct. 2011:7381372011. View Article : Google Scholar : PubMed/NCBI

16. 

Katagiri K, Yokosawa H, Kinashi T, et al: Ubiquitin-proteasome system is involved in induction of LFA-1/ICAM-1-dependent adhesion of HL-60 cells. J Leukoc Biol. 65:778–785. 1999.PubMed/NCBI

17. 

Lewin G, Maciuk A, Thoret S, et al: Semisynthesis of natural flavones inhibiting tubulin polymerization, from hesperidin. J Nat Prod. 73:702–706. 2010. View Article : Google Scholar : PubMed/NCBI

18. 

Fukushima H, Hirano T and Oka K: Staphylococcus aureus-superantigen decreases FKBP51 mRNA expression and cell-response to suppressive efficacy of a glucocorticoid in human peripheral blood mononuclear cells: possible implication of mitogen-activated protein kinase pathways. Eur J Pharmacol. 570:222–228. 2007. View Article : Google Scholar

19. 

Imai M, Kikuchi H, Denda T, et al: Cytotoxic effects of flavonoids against a human colon cancer derived cell line, COLO 201: a potential natural anti-cancer substance. Cancer Lett. 276:74–80. 2009. View Article : Google Scholar : PubMed/NCBI

20. 

Yuan B, Ohyama K, Bessho T, et al: Contribution of inducible nitric oxide synthase and cyclooxygenase-2 to apoptosis induction in smooth chorion trophoblast cells of human fetal membrane tissues. Biochem Biophys Res Commun. 341:822–827. 2006. View Article : Google Scholar

21. 

Yourno J, Burkart P, Mastropaolo W, et al: Monocyte nonspecific esterase. Enzymologic characterization of a neutral serine esterase associated with myeloid cells. J Histochem Cytochem. 34:727–733. 1986. View Article : Google Scholar

22. 

Solary E, Bertrand R and Pommier Y: Apoptosis of human leukemic HL-60 cells induced to differentiate by phorbol ester treatment. Leukemia. 8:792–797. 1994.PubMed/NCBI

23. 

Murao S, Gemmell MA, Callaham MF, et al: Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate. Cancer Res. 43:4989–4996. 1983.PubMed/NCBI

24. 

Imai M, Yuan B, Kikuchi H, et al: Growth inhibition of a human colon carcinoma cell, COLO 201, by a natural product, Vitex agnus-castus fruits extract, in vivo and in vitro. Adv Biol Chem. 2:20–28. 2012. View Article : Google Scholar

25. 

Prieto J, Eklund A and Patarroyo M: Regulated expression of integrins and other adhesion molecules during differentiation of monocytes into macrophages. Cell Immunol. 156:191–211. 1994. View Article : Google Scholar : PubMed/NCBI

26. 

Lee SM, Lee YJ, Kim YC, et al: Vascular protective role of vitexicarpin isolated from Vitex rotundifolia in human umbilical vein endothelial cells. Inflammation. 35:584–593. 2012. View Article : Google Scholar : PubMed/NCBI

27. 

Hazlehurst LA and Dalton WS: Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies. Cancer Metastasis Rev. 20:43–50. 2001. View Article : Google Scholar : PubMed/NCBI

28. 

Li ZW and Dalton WS: Tumor microenvironment and drug resistance in hematologic malignancies. Blood Rev. 20:333–342. 2006. View Article : Google Scholar : PubMed/NCBI

29. 

Imai M, Kikuchi H, Yuan B, et al: Enhanced growth inhibitory effect of 5-fluorouracil in combination with Vitex agnus-castus fruits extract against a human colon adenocarcinoma cell line, COLO 201. J Clin Clin Med. 6:14–19. 2011.

30. 

Zhou Y, Liu YE, Cao J, et al: Vitexins, nature-derived lignan compounds, induce apoptosis and suppress tumor growth. Clin Cancer Res. 15:5161–5169. 2009. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Kikuchi H, Yuan B, Nishimura Y, Imai M, Furutani R, Kamoi S, Seno M, Fukushima S, Hazama S, Hirobe C, Hirobe C, et al: Cytotoxicity of Vitex agnus-castus fruit extract and its major component, casticin, correlates with differentiation status in leukemia cell lines. Int J Oncol 43: 1976-1984, 2013.
APA
Kikuchi, H., Yuan, B., Nishimura, Y., Imai, M., Furutani, R., Kamoi, S. ... Toyoda, H. (2013). Cytotoxicity of Vitex agnus-castus fruit extract and its major component, casticin, correlates with differentiation status in leukemia cell lines. International Journal of Oncology, 43, 1976-1984. https://doi.org/10.3892/ijo.2013.2133
MLA
Kikuchi, H., Yuan, B., Nishimura, Y., Imai, M., Furutani, R., Kamoi, S., Seno, M., Fukushima, S., Hazama, S., Hirobe, C., Ohyama, K., Hu, X., Takagi, N., Hirano, T., Toyoda, H."Cytotoxicity of Vitex agnus-castus fruit extract and its major component, casticin, correlates with differentiation status in leukemia cell lines". International Journal of Oncology 43.6 (2013): 1976-1984.
Chicago
Kikuchi, H., Yuan, B., Nishimura, Y., Imai, M., Furutani, R., Kamoi, S., Seno, M., Fukushima, S., Hazama, S., Hirobe, C., Ohyama, K., Hu, X., Takagi, N., Hirano, T., Toyoda, H."Cytotoxicity of Vitex agnus-castus fruit extract and its major component, casticin, correlates with differentiation status in leukemia cell lines". International Journal of Oncology 43, no. 6 (2013): 1976-1984. https://doi.org/10.3892/ijo.2013.2133
Copy and paste a formatted citation
x
Spandidos Publications style
Kikuchi H, Yuan B, Nishimura Y, Imai M, Furutani R, Kamoi S, Seno M, Fukushima S, Hazama S, Hirobe C, Hirobe C, et al: Cytotoxicity of Vitex agnus-castus fruit extract and its major component, casticin, correlates with differentiation status in leukemia cell lines. Int J Oncol 43: 1976-1984, 2013.
APA
Kikuchi, H., Yuan, B., Nishimura, Y., Imai, M., Furutani, R., Kamoi, S. ... Toyoda, H. (2013). Cytotoxicity of Vitex agnus-castus fruit extract and its major component, casticin, correlates with differentiation status in leukemia cell lines. International Journal of Oncology, 43, 1976-1984. https://doi.org/10.3892/ijo.2013.2133
MLA
Kikuchi, H., Yuan, B., Nishimura, Y., Imai, M., Furutani, R., Kamoi, S., Seno, M., Fukushima, S., Hazama, S., Hirobe, C., Ohyama, K., Hu, X., Takagi, N., Hirano, T., Toyoda, H."Cytotoxicity of Vitex agnus-castus fruit extract and its major component, casticin, correlates with differentiation status in leukemia cell lines". International Journal of Oncology 43.6 (2013): 1976-1984.
Chicago
Kikuchi, H., Yuan, B., Nishimura, Y., Imai, M., Furutani, R., Kamoi, S., Seno, M., Fukushima, S., Hazama, S., Hirobe, C., Ohyama, K., Hu, X., Takagi, N., Hirano, T., Toyoda, H."Cytotoxicity of Vitex agnus-castus fruit extract and its major component, casticin, correlates with differentiation status in leukemia cell lines". International Journal of Oncology 43, no. 6 (2013): 1976-1984. https://doi.org/10.3892/ijo.2013.2133
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team